A vision for the future of allogeneic hematopoietic stem cell transplantation in the next decade

Affiliations

¹ Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
² Department of Hematology and Cell Therapy, European Society for Blood and Marrow Transplantation Global Committee, Hôpital Saint-Antoine AP-HP, Paris Sorbonne University, Paris 75012, France. Electronic address: gorinclaude@gmail.com.
³ Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China; Peking-Tsinghua Center for Life Sciences, Beijing 100871, China. Electronic address: huangxiaojun@bjmu.edu.cn.

Meng Lv et al. Sci Bull (Beijing). 2022.

. 2022 Oct 15;67(19):1921-1924.

doi: 10.1016/j.scib.2022.09.004. Epub 2022 Sep 5.

¹ Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
² Department of Hematology and Cell Therapy, European Society for Blood and Marrow Transplantation Global Committee, Hôpital Saint-Antoine AP-HP, Paris Sorbonne University, Paris 75012, France. Electronic address: gorinclaude@gmail.com.
³ Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China; Peking-Tsinghua Center for Life Sciences, Beijing 100871, China. Electronic address: huangxiaojun@bjmu.edu.cn.

No abstract available

Conflict of interest statement

Conflict of interest The authors declare that they have no conflict of interest.